Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection (Q37287855)

From Wikidata
Jump to navigation Jump to search
scientific article published on 08 August 2016
edit
Language Label Description Also known as
English
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
scientific article published on 08 August 2016

    Statements

    Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection (English)
    Christopher Lucasti
    Liviu Vasile
    Dorel Sandesc
    Donatas Venskutonis
    Patrick McLeroth
    Mallika Lala
    Matthew L Rizk
    Michelle L Brown
    Maria C Losada
    Alison Pedley
    Nicholas A Kartsonis
    Amanda Paschke
    8 August 2016
    6234-6243

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit